Evolution and modulation of antigen-specific T cell responses in melanoma patients

scRNA+TCRab-seq and TCRb-seq data sets from patients with melanoma treated with anti-LAG3+anti-PD1 therapy from 0 m, 1 m and 3 m following therapy本数据集包含接受抗LAG3联合抗PD1治疗的黑色素瘤患者在治疗后0个月、1个月及3个月时的单细胞RNA测序联合T细胞受体αβ链测序（scRNA+TCRab-seq）与T细胞受体β链测序（TCRb-seq）数据。